Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Mar 4, 2014

29777_dirs_2014-03-04_61ac4f8f-1c82-4f28-b4e1-862e42550c2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-28

Reporting Person: Landgraf John C (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 Common shares without par value F 15307 $39.79 Disposed 112424 Direct
2014-03-03 Common shares without par value S 8610 $39.3700 Disposed 103814 Direct
2014-03-03 Common shares without par value S 1377 $39.3800 Disposed 102437 Direct
2014-03-03 Common shares without par value S 192 $39.3900 Disposed 102245 Direct
2014-03-03 Common shares without par value S 6307 $39.4000 Disposed 95938 Direct
2014-03-03 Common shares without par value S 807 $39.4010 Disposed 95131 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 18570 Indirect
Common shares without par value 167 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his son.